Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders

By Carroll Richard T.   Bhatia Deepak   Geldenhuys Werner   Bhatia Ruchi   Miladore Nicholas   Bishayee Anupam   Sutariya Vijaykumar  

Journal of Drug Targeting, Vol. 18, Iss. 9, 2010-11 ,pp. : 665-674

Informa Healthcare

Access to resources Recommend Favorite

Nose-to-Brain Drug Delivery by Nanoparticles in the Treatment of Neurological Disorders

By  

Current Medicinal Chemistry, Vol. 21, Iss. 37, 2014-12 ,pp. : 4247-4256

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Brain Phospholipase A2 by Antimalarial Drugs: Implications for Neuroprotection in Neurological Disorders

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 5, 2005-10 ,pp. : 379-392

Bentham Science Publishers

Access to resources Recommend Favorite

Global Expression Studies of Schizophrenic Brain: A Meta-Analysis Study Linking Neurological Immune System with Psychological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 4, 2016-05 ,pp. : 477-488

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: W(e)nt to the Brain: Wnt Signaling in Neurological Disorders)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 736-736

Bentham Science Publishers

Access to resources Recommend Favorite